Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.08
COO's Cash to Debt is ranked lower than
55% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. COO: 0.08 )
COO' s 10-Year Cash to Debt Range
Min: 0   Max: 1.92
Current: 0.08

0
1.92
Equity to Asset 0.78
COO's Equity to Asset is ranked higher than
86% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. COO: 0.78 )
COO' s 10-Year Equity to Asset Range
Min: -0.09   Max: 0.8
Current: 0.78

-0.09
0.8
Interest Coverage 33.37
COO's Interest Coverage is ranked higher than
73% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.61 vs. COO: 33.37 )
COO' s 10-Year Interest Coverage Range
Min: 1.07   Max: 33.37
Current: 33.37

1.07
33.37
F-Score: 6
Z-Score: 6.85
M-Score: -2.70
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 19.27
COO's Operating margin (%) is ranked higher than
89% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.44 vs. COO: 19.27 )
COO' s 10-Year Operating margin (%) Range
Min: 4.82   Max: 23.82
Current: 19.27

4.82
23.82
Net-margin (%) 18.65
COO's Net-margin (%) is ranked higher than
92% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.65 vs. COO: 18.65 )
COO' s 10-Year Net-margin (%) Range
Min: -1.18   Max: 34.8
Current: 18.65

-1.18
34.8
ROE (%) 12.32
COO's ROE (%) is ranked higher than
83% of the 283 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. COO: 12.32 )
COO' s 10-Year ROE (%) Range
Min: -0.77   Max: 108.5
Current: 12.32

-0.77
108.5
ROA (%) 9.44
COO's ROA (%) is ranked higher than
87% of the 290 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.24 vs. COO: 9.44 )
COO' s 10-Year ROA (%) Range
Min: -0.43   Max: 18.11
Current: 9.44

-0.43
18.11
ROC (Joel Greenblatt) (%) 27.04
COO's ROC (Joel Greenblatt) (%) is ranked higher than
81% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.38 vs. COO: 27.04 )
COO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 5.22   Max: 52.76
Current: 27.04

5.22
52.76
Revenue Growth (%) 8.70
COO's Revenue Growth (%) is ranked higher than
79% of the 248 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. COO: 8.70 )
COO' s 10-Year Revenue Growth (%) Range
Min: 4.8   Max: 27.8
Current: 8.7

4.8
27.8
EBITDA Growth (%) 17.90
COO's EBITDA Growth (%) is ranked higher than
89% of the 210 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.40 vs. COO: 17.90 )
COO' s 10-Year EBITDA Growth (%) Range
Min: -8.6   Max: 62.2
Current: 17.9

-8.6
62.2
EPS Growth (%) 34.90
COO's EPS Growth (%) is ranked higher than
92% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. COO: 34.90 )
COO' s 10-Year EPS Growth (%) Range
Min: -15.2   Max: 474.9
Current: 34.9

-15.2
474.9
» COO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

COO Guru Trades in Q1 2013

Paul Tudor Jones 4,500 sh (New)
Manning & Napier Advisors, Inc 126,040 sh (New)
Caxton Associates 55,000 sh (New)
Ken Fisher 55,000 sh (+33.17%)
Mario Gabelli 42,000 sh (-4.55%)
Jim Simons 349,898 sh (-12.22%)
Steven Cohen 127,503 sh (-54.06%)
» More
Q2 2013

COO Guru Trades in Q2 2013

RS Investment Management 81,885 sh (New)
Caxton Associates 59,479 sh (+8.14%)
Manning & Napier Advisors, Inc 131,540 sh (+4.36%)
Ken Fisher 57,250 sh (+4.09%)
Caxton Associates 130,000 sh (unchged)
Mario Gabelli 38,000 sh (-9.52%)
Paul Tudor Jones 2,800 sh (-37.78%)
Steven Cohen 36,933 sh (-71.03%)
Jim Simons 16,300 sh (-95.34%)
» More
Q3 2013

COO Guru Trades in Q3 2013

Chuck Royce 500 sh (New)
RS Investment Management 177,735 sh (+117.05%)
Jim Simons 31,600 sh (+93.87%)
Paul Tudor Jones 4,200 sh (+50%)
Ken Fisher 62,650 sh (+9.43%)
Manning & Napier Advisors, Inc Sold Out
Caxton Associates Sold Out
Mario Gabelli 34,500 sh (-9.21%)
Steven Cohen 3,218 sh (-91.29%)
» More
Q4 2013

COO Guru Trades in Q4 2013

Bill Frels 3,000 sh (New)
Chuck Royce 3,800 sh (+660%)
Steven Cohen 15,338 sh (+376.63%)
Jim Simons 129,498 sh (+309.8%)
RS Investment Management Sold Out
Mario Gabelli 30,500 sh (-11.59%)
Ken Fisher 53,850 sh (-14.05%)
Paul Tudor Jones 3,406 sh (-18.9%)
» More
» Details

Insider Trades

Latest Guru Trades with COO

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ray Dalio 2012-12-31 Sold Out 0.02%$89.4 - $100.67 $ 129.1836%0
Steve Mandel 2012-09-30 Sold Out 0.95%$72.45 - $94.83 $ 129.1858%0
Ray Dalio 2012-09-30 New Buy0.02%$72.45 - $94.83 $ 129.1858%14658
Steve Mandel 2012-06-30 New Buy0.95%$76.63 - $88.45 $ 129.1855%2017657
Richard Perry 2012-03-31 Sold Out 0.44%$68.74 - $81.96 $ 129.1884%0
Joel Greenblatt 2012-03-31 Sold Out 0.04%$68.74 - $81.96 $ 129.1884%0
Mario Gabelli 2012-03-31 Reduce -25.25%0.01%$68.74 - $81.96 $ 129.1884%75500
Richard Perry 2011-12-31 New Buy0.44%$56.64 - $78.59 $ 129.1892%100000
Ray Dalio 2011-12-31 Sold Out 0.13%$56.64 - $78.59 $ 129.1892%0
Joel Greenblatt 2011-12-31 New Buy0.04%$56.64 - $78.59 $ 129.1892%4189
Ray Dalio 2011-09-30 Add 38.62%0.04%$63.8 - $83 $ 129.1870%108244
Joel Greenblatt 2011-06-30 Sold Out 0.18%$69.16 - $77.5 $ 129.1875%0
John Paulson 2011-06-30 Sold Out 0.05%$69.16 - $77.5 $ 129.1875%0
Joel Greenblatt 2011-03-31 Add 41.46%0.05%$56.06 - $70.56 $ 129.18109%8830
John Paulson 2011-03-31 New Buy0.05%$56.06 - $70.56 $ 129.18109%250600
Mario Gabelli 2011-03-31 Reduce -36.28%0.04%$56.06 - $70.56 $ 129.18109%137000
George Soros 2011-03-31 Sold Out $56.06 - $70.56 $ 129.18109%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 21.70
COO's P/E(ttm) is ranked higher than
72% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.10 vs. COO: 21.70 )
COO' s 10-Year P/E(ttm) Range
Min: 7.98   Max: 1011.75
Current: 21.7

7.98
1011.75
P/B 2.50
COO's P/B is ranked higher than
70% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. COO: 2.50 )
COO' s 10-Year P/B Range
Min: 0.37   Max: 4.45
Current: 2.5

0.37
4.45
P/S 3.97
COO's P/S is ranked lower than
62% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.60 vs. COO: 3.97 )
COO' s 10-Year P/S Range
Min: 0.51   Max: 5.98
Current: 3.97

0.51
5.98
PFCF 28.30
COO's PFCF is ranked higher than
59% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.00 vs. COO: 28.30 )
COO' s 10-Year PFCF Range
Min: 7.34   Max: 342.65
Current: 28.3

7.34
342.65
EV-to-EBIT 20.80
COO's EV-to-EBIT is ranked higher than
54% of the 247 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.32 vs. COO: 20.80 )
COO' s 10-Year EV-to-EBIT Range
Min: 8.2   Max: 68.2
Current: 20.8

8.2
68.2
PEG 1.40
COO's PEG is ranked higher than
79% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.13 vs. COO: 1.40 )
COO' s 10-Year PEG Range
Min: 0.33   Max: 31.7
Current: 1.4

0.33
31.7
Shiller P/E 33.60
COO's Shiller P/E is ranked higher than
50% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.28 vs. COO: 33.60 )
COO' s 10-Year Shiller P/E Range
Min: 6.7   Max: 49.67
Current: 33.6

6.7
49.67

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.05
COO's Dividend Yield is ranked lower than
94% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. COO: 0.05 )
COO' s 10-Year Dividend Yield Range
Min: 0.04   Max: 0.33
Current: 0.05

0.04
0.33
Dividend Payout 0.01
COO's Dividend Payout is ranked higher than
99% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.33 vs. COO: 0.01 )
COO' s 10-Year Dividend Payout Range
Min: 0.02   Max: 0.25
Current: 0.01

0.02
0.25
Yield on cost (5-Year) 0.10
COO's Yield on cost (5-Year) is ranked lower than
92% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. COO: 0.10 )
COO' s 10-Year Yield on cost (5-Year) Range
Min: 0.04   Max: 0.33
Current: 0.1

0.04
0.33
Share Buyback Rate -2.20
COO's Share Buyback Rate is ranked higher than
77% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.70 vs. COO: -2.20 )
COO' s 10-Year Share Buyback Rate Range
Min: 1.5   Max: -13
Current: -2.2

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 7.20
COO's Price/Tangible Book is ranked lower than
65% of the 232 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. COO: 7.20 )
COO' s 10-Year Price/Tangible Book Range
Min: 3.32   Max: 1473.33
Current: 7.2

3.32
1473.33
Price/DCF (Projected) 1.50
COO's Price/DCF (Projected) is ranked higher than
65% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. COO: 1.50 )
COO' s 10-Year Price/DCF (Projected) Range
Min: 0.55   Max: 5.86
Current: 1.5

0.55
5.86
Price/Median PS Value 1.40
COO's Price/Median PS Value is ranked lower than
51% of the 268 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. COO: 1.40 )
COO' s 10-Year Price/Median PS Value Range
Min: 0.21   Max: 2.59
Current: 1.4

0.21
2.59
Price/Peter Lynch Fair Value 1.40
COO's Price/Peter Lynch Fair Value is ranked higher than
86% of the 76 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. COO: 1.40 )
COO' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.6   Max: 70
Current: 1.4

0.6
70
Price/Graham Number 2.60
COO's Price/Graham Number is ranked higher than
50% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. COO: 2.60 )
COO' s 10-Year Price/Graham Number Range
Min: 0.77   Max: 49.66
Current: 2.6

0.77
49.66
Earnings Yield (Greenblatt) 4.80
COO's Earnings Yield (Greenblatt) is ranked higher than
58% of the 226 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. COO: 4.80 )
COO' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.5   Max: 12.2
Current: 4.8

1.5
12.2
Forward Rate of Return (Yacktman) 17.83
COO's Forward Rate of Return (Yacktman) is ranked higher than
92% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. COO: 17.83 )
COO' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -1.4   Max: 46.3
Current: 17.83

-1.4
46.3

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, ISRG » details
Traded in other countries:CP6.Germany
Cooper Companies is a Delaware corporation organized in 1980. The Company is a medical device company. The Company operates through two business units: CooperVision, Inc. and CooperSurgical, Inc. They compete on the basis of product quality and differentiation, technological benefit, service and reliability. CooperVision is engaged in the manufacture and sale of products for contact lens wearers. CooperVision develops, manufactures and markets monthly, two-week and single-use contact lenses, including advanced materials and optics. The contact lens market has two major product categories: Spherical lenses including lenses that correct near- and farsightedness uncomplicated by more complex visual defects; and toric and multifocal lenses including lenses that address more complex visual defects such as astigmatism and presbyopia by adding optical properties of cylinder and axis, which correct for irregularities in the shape of the cornea. CooperVision's products are manufactured at its facilities located in Hampshire, United Kingdom, Juana Diaz, Puerto Rico, and West Henrietta, New York. It uses three different manufacturing processes to produce its lenses: lathing, cast molding and FIPS. CooperVision distributes products from West Henrietta, New York, Fareham, United Kingdom, Liege, Belgium, and other international distribution facilities. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical's offers products to aid clinicians in the management and treatment of commonly seen conditions. CooperSurgical customers are healthcare professionals and institutions providing care to and for women. CooperSurgical products support the point of healthcare delivery in the hospital, clinicians office and fertility clinics. CooperSurgical's manufacturing and distribution facilities are located in Trumbull, Connecticut, Malov, Denmark, Pasadena, California, Stafford, Texas, Golden, Colorado, and Berlin, Germany. The Company owns several manufacturing and research and development facilities, including 205,850 square feet in Hamble, United Kingdom, 49,500 square feet in Scottsville, New York, 63,787 square feet in Malov, Denmark, and 33,630 square feet in Stafford, Texas. The Company's products and medical devices are subject to extensive regulation by the United States Food and Drug Administration in the United States and other regulatory bodies abroad. The Company also owns certain trade secrets, copyrights, know-how and other intellectual property.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide